MLYS · Mineralys Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Brian Taylor Slingsby Director | ▼ Sell | Open Market | 7,805,718 Shares held | 9/22/2026 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Open Market | 5,825,521 Shares held | 3/30/2026 | View profile |
| Samsara BioCapital GP, LLC 10% Owner | ▲ Buy | Open Market | 5,674,916 Shares held | 3/13/2025 | View profile |
| HBM Healthcare Investments (Cayman) Ltd. 10% Owner | ▲ Buy | Open Market | 3,218,106 Shares held | 2/14/2023 | View profile |
| Jon Congleton Chief Executive Officer | ▼ Sell | Open Market | 528,621 Shares held | 9/30/2026 | View profile |
| James J. Ferguson III Chief Medical Officer | ▲ Buy | Grant | 102,400 Shares held | 8/10/2026 | View profile |
| David Malcom Rodman Chief Medical Officer | ▼ Sell | Open Market | 51,384 Shares held | 8/10/2026 | View profile |
| Adam Scott Levy CFO, Chief Bus. Off. and Secy. | ▲ Buy | Grant | 48,538 Shares held | 2/19/2026 | View profile |
| Eric Warren Chief Commercial Officer | ▼ Sell | Open Market | 38,400 Shares held | 9/21/2026 | View profile |
| Srinivas Akkaraju Director | ▲ Buy | Grant | 6,200 Shares held | 2/19/2026 | View profile |
| Derek DiRocco Director | ▲ Buy | Grant | 6,200 Shares held | 2/19/2026 | View profile |
| Daphne Karydas Director | ▼ Sell | Open Market | 6,200 Shares held | 9/15/2026 | View profile |
| Glenn Sblendorio Director | ▲ Buy | Grant | 6,200 Shares held | 2/19/2026 | View profile |
| Alexander M. Gold Director | ▲ Buy | Grant | 6,200 Shares held | 2/19/2026 | View profile |
Transaction History
| Jon Congleton | ▼ Sell | Open Market | 75,000 | $1.9M | 9/30/2026 |
| Brian Taylor Slingsby | ▼ Sell | Open Market | 104,320 | $3.0M | 9/22/2026 |
| Eric Warren | ▲ Buy | Option Exercise | 7,438 | $98K | 9/21/2026 |
| Eric Warren | ▼ Sell | Open Market | 7,438 | $209K | 9/21/2026 |
| Daphne Karydas | ▲ Buy | Option Exercise | 3,000 | $36K | 9/15/2026 |
| Daphne Karydas | ▼ Sell | Open Market | 3,000 | $86K | 9/15/2026 |
| Eric Warren | ▲ Buy | Option Exercise | 7,437 | $98K | 8/21/2026 |
| Eric Warren | ▼ Sell | Open Market | 7,437 | $193K | 8/21/2026 |
| James J. Ferguson III | ▲ Buy | Grant | 102,400 | $0 | 8/10/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,170 | $35K | 8/10/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,170 | $59K | 8/10/2026 |
| Eric Warren | ▲ Buy | Option Exercise | 7,438 | $98K | 7/21/2026 |
| Eric Warren | ▼ Sell | Open Market | 7,438 | $200K | 7/21/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 416 | $6K | 7/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 416 | $11K | 7/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,349 | $169K | 7/15/2026 |
| Jon Congleton | ▼ Sell | Open Market | 10,700 | $291K | 7/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,542 | $36K | 7/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,167 | $59K | 7/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 7/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 14,058 | $388K | 7/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,171 | $35K | 7/9/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,171 | $66K | 7/9/2026 |
| Jon Congleton | ▼ Sell | Open Market | 58,000 | $1.5M | 6/30/2026 |
| Jon Congleton | ▼ Sell | Open Market | 17,000 | $456K | 6/30/2026 |
| Eric Warren | ▲ Buy | Option Exercise | 104,124 | $1.4M | 6/26/2026 |
| Eric Warren | ▼ Sell | Open Market | 104,124 | $2.7M | 6/26/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 417 | $6K | 6/17/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,167 | $59K | 6/17/2026 |
| Daphne Karydas | ▲ Buy | Option Exercise | 3,000 | $36K | 6/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 4,584 | $115K | 6/17/2026 |
| Daphne Karydas | ▼ Sell | Open Market | 3,000 | $75K | 6/17/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,542 | $36K | 6/15/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 9,890 | $235K | 6/15/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 6/12/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,349 | $152K | 6/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,170 | $35K | 6/10/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,170 | $54K | 6/10/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 417 | $6K | 5/18/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 417 | $11K | 5/18/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,541 | $36K | 5/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,166 | $59K | 5/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 14,056 | $402K | 5/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,348 | $7K | 5/12/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,348 | $186K | 5/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,171 | $35K | 5/11/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,171 | $65K | 5/11/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 416 | $6K | 4/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 416 | $13K | 4/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,348 | $176K | 4/15/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 4/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,542 | $36K | 4/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,167 | $59K | 4/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 14,058 | $373K | 4/13/2026 |
| Jon Congleton | ▼ Sell | Open Market | 15,730 | $422K | 4/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,170 | $35K | 4/9/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,170 | $59K | 4/9/2026 |
| Jon Congleton | ▼ Sell | Open Market | 55,183 | $1.5M | 3/31/2026 |
| Jon Congleton | ▼ Sell | Open Market | 453 | $12K | 3/31/2026 |
| Daphne Karydas | ▲ Buy | Option Exercise | 3,000 | $36K | 3/31/2026 |
| Daphne Karydas | ▼ Sell | Open Market | 3,000 | $75K | 3/31/2026 |
| Jon Congleton | ▼ Sell | Open Market | 19,364 | $494K | 3/31/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 58,300 | $1.4M | 3/30/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 310,700 | $7.4M | 3/27/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 417 | $6K | 3/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 417 | $11K | 3/17/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,542 | $36K | 3/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,167 | $59K | 3/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 10,726 | $278K | 3/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 3,079 | $84K | 3/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 253 | $7K | 3/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,348 | $174K | 3/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,348 | $7K | 3/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,171 | $35K | 3/9/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,171 | $58K | 3/9/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| Jon Congleton | ▲ Buy | Grant | 140,900 | $0 | 2/19/2026 |
| Alexander M. Gold | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| Daphne Karydas | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| Brian Taylor Slingsby | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| Brian Taylor Slingsby | ▼ Sell | Other | 6,200 | $0 | 2/19/2026 |
| Glenn Sblendorio | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| Brian Taylor Slingsby | ▼ Sell | Other | 6,200 | $0 | 2/19/2026 |
| Srinivas Akkaraju | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| Derek DiRocco | ▲ Buy | Grant | 6,200 | $0 | 2/19/2026 |
| David Malcom Rodman | ▲ Buy | Grant | 38,400 | $0 | 2/19/2026 |
| Adam Scott Levy | ▲ Buy | Grant | 39,900 | $0 | 2/19/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 417 | $6K | 2/17/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 417 | $12K | 2/17/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,541 | $36K | 2/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 3,541 | $97K | 2/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,166 | $59K | 2/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 4,166 | $114K | 2/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,348 | $175K | 2/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 2/12/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 5,828 | $169K | 2/12/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 521 | $15K | 2/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,171 | $35K | 2/9/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,171 | $66K | 2/9/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 416 | $6K | 1/20/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 416 | $13K | 1/20/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 11,367 | $371K | 1/14/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 4,167 | $59K | 1/13/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 7,709 | $252K | 1/13/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,542 | $36K | 1/13/2026 |
| Jon Congleton | ▼ Sell | Open Market | 9,119 | $294K | 1/12/2026 |
| Jon Congleton | ▼ Sell | Open Market | 7,117 | $236K | 1/12/2026 |
| Adam Scott Levy | ▼ Sell | Open Market | 10,758 | $346K | 1/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,348 | $7K | 1/12/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 6,348 | $205K | 1/12/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 2,170 | $35K | 1/9/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,170 | $72K | 1/9/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 28,038 | $30K | 1/5/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 10,121 | $156K | 1/5/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 26,069 | $266K | 1/5/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 53,630 | $858K | 1/5/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 67,473 | $961K | 1/5/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 139,245 | $4.8M | 1/5/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 53,470 | $1.9M | 1/5/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 10,053 | $11K | 1/2/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 3,629 | $56K | 1/2/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 9,347 | $95K | 1/2/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 20,168 | $323K | 1/2/2026 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 24,193 | $345K | 1/2/2026 |
| David Malcom Rodman | ▼ Sell | Open Market | 70,037 | $2.5M | 1/2/2026 |
| Jon Congleton | ▲ Buy | Option Exercise | 24,082 | $13K | 11/21/2025 |
| Brian Taylor Slingsby | ▼ Sell | Open Market | 1,000,000 | $43.4M | 11/20/2025 |
| Daphne Karydas | ▲ Buy | Option Exercise | 15,000 | $153K | 11/13/2025 |
| Daphne Karydas | ▼ Sell | Open Market | 10,115 | $463K | 11/13/2025 |
| Daphne Karydas | ▼ Sell | Open Market | 4,885 | $226K | 11/13/2025 |
| Alexander M. Gold | ▲ Buy | Option Exercise | 2,742 | $28K | 11/13/2025 |
| Alexander M. Gold | ▲ Buy | Option Exercise | 10,000 | $127K | 11/13/2025 |
| Alexander M. Gold | ▼ Sell | Open Market | 12,742 | $593K | 11/13/2025 |
| Alexander M. Gold | ▲ Buy | Option Exercise | 6,933 | $71K | 11/12/2025 |
| Alexander M. Gold | ▼ Sell | Open Market | 5,000 | $233K | 11/12/2025 |
| Alexander M. Gold | ▼ Sell | Open Market | 1,933 | $91K | 11/12/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 32,718 | $1.5M | 11/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 12,806 | $533K | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 38,900 | $1.8M | 11/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 8,862 | $375K | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 8,456 | $382K | 11/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 112,275 | $5.1M | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 4,142 | $180K | 11/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 4,000 | $174K | 11/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 29,207 | $1.3M | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 8,485 | $359K | 11/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 32,850 | $1.5M | 11/11/2025 |
| Alexander M. Gold | ▲ Buy | Option Exercise | 15,000 | $153K | 11/11/2025 |
| Alexander M. Gold | ▼ Sell | Open Market | 10,000 | $424K | 11/11/2025 |
| Adam Scott Levy | ▲ Buy | Option Exercise | 20,547 | $210K | 11/11/2025 |
| Adam Scott Levy | ▲ Buy | Option Exercise | 34,414 | $551K | 11/11/2025 |
| Adam Scott Levy | ▲ Buy | Option Exercise | 44,079 | $628K | 11/11/2025 |
| Adam Scott Levy | ▲ Buy | Option Exercise | 6,613 | $102K | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 1,015 | $43K | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 11,295 | $473K | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 1,561 | $67K | 11/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 12,952 | $539K | 11/11/2025 |
| Alexander M. Gold | ▼ Sell | Open Market | 5,000 | $235K | 11/11/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 10,369 | $446K | 10/15/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 7,366 | $309K | 10/13/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 3,392 | $143K | 10/13/2025 |
| Jon Congleton | ▼ Sell | Open Market | 13,548 | $578K | 10/13/2025 |
| Jon Congleton | ▼ Sell | Open Market | 1,552 | $67K | 10/13/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 9,302 | $334K | 9/15/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,065 | $75K | 9/15/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 588,235 | $15.0M | 9/4/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,176,470 | $30.0M | 9/4/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 11,365 | $147K | 8/13/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 8/12/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 51,500 | $757K | 7/30/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 8,425 | $127K | 7/30/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 807 | $11K | 7/29/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 12,946 | $182K | 7/28/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 11,366 | $166K | 7/14/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 7/14/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 10,758 | $155K | 7/11/2025 |
| Jon Congleton | ▼ Sell | Open Market | 15,884 | $230K | 7/11/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 11,366 | $166K | 6/13/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,348 | $7K | 6/12/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 11,366 | $174K | 5/14/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 5/12/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,348 | $7K | 4/14/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 8,400 | $125K | 4/14/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,966 | $41K | 4/14/2025 |
| Jon Congleton | ▼ Sell | Open Market | 15,319 | $187K | 4/11/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 10,757 | $130K | 4/11/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 1,606 | $2K | 4/1/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 2,791 | $45K | 4/1/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 22,406 | $376K | 4/1/2025 |
| David Malcom Rodman | ▼ Sell | Open Market | 30,574 | $459K | 4/1/2025 |
| Samsara BioCapital GP, LLC | ▲ Buy | Open Market | 600,000 | $8.1M | 3/13/2025 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,296,296 | $17.5M | 3/13/2025 |
| Brian Taylor Slingsby | ▲ Buy | Open Market | 259,259 | $3.5M | 3/13/2025 |
| Srinivas Akkaraju | ▲ Buy | Open Market | 600,000 | $8.1M | 3/13/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,349 | $7K | 3/12/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 6,348 | $7K | 2/12/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 10,657 | $97K | 1/13/2025 |
| Jon Congleton | ▼ Sell | Open Market | 18,333 | $166K | 1/13/2025 |
| Adam Scott Levy | ▼ Sell | Open Market | 100 | $963 | 1/13/2025 |
| David Malcom Rodman | ▲ Buy | Option Exercise | 5,018 | $3K | 1/13/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Mineralys Presents Phase 3 Data, Receives Mixed Analyst Views
Mineralys Therapeutics presented new data from its pivotal Phase 3 Launch-HTN study at the American Heart Association Hypertension Scientific Sessions 2026. Following this update, UBS initiated coverage with a Neutral rating and a $29 price target, while HC Wainwright reiterated a Buy rating with a $56 target. The stock is currently trading near its support level, reflecting the divided analyst opinions on the company's outlook.
Mineralys Presents Phase 3 Data, Receives Mixed Analyst Views. Mineralys Therapeutics presented new data from its pivotal Phase 3 Launch-HTN study at the American Heart Association Hypertension Scientific Sessions 2026. Following this update, UBS initiated coverage with a Neutral rating and a $29 price target, while HC Wainwright reiterated a Buy rating with a $56 target. The stock is currently trading near its support level, reflecting the divided analyst opinions on the company's outlook.